Skip to main content

Advertisement

Table 3 Toxicities during induction chemotherapy

From: Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer

  arm A (n = 25) arm B (n = 24)
Grade 1 2 3 4 1 2 3 4
Leukopenia 1 2 1 - - 2 2 1
Neutropenia - - 8 9 - 1 5 4
Neutropenic fever - - 1 - - - - -
Thrombocytopenia - - - - 1 4 1 2
Amenia 1 - - - - - 1 -
Low Hemoglobin - - - - 1 2 - -
AST/ALT 3 2 1 - - 2 3 -
Nausea 3 1 - - 3 1 - -
Pain - - - - 1 1 - -
Arthralgia 2 2 - - - - - -
Myalgia 2 3 - - - - - -
Skin rash 1 2 1 - 1 2 1 -
Conspitation 2 - - - 3 - - -
Fever 2 - - - - 2 - -
Fatigue 3 1 - - 1 1 - -
Peripheral Neurotoxicies 2 1 2 - - - - -
Pruritus - 1 - - - 1 - -
Appetite loss 1 2 - - 1 1 - -